Seres therapeutics announces $250 million debt financing with oaktree

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, today announced that it has entered into a new $250 million senior secured debt facility (“term loan facility”) provided by funds managed by oaktree capital management, l.p. (“oaktree”). the company drew the first tranche of $110 million at closing, with three additional tranches available. these additional tranches include $90 million that will be available in two tranches of.
MCRB Ratings Summary
MCRB Quant Ranking